Suppr超能文献

55个经证实或疑似遗传性非息肉病性结直肠癌家系中的DNA错配修复基因突变

DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer.

作者信息

Nyström-Lahti M, Wu Y, Moisio A L, Hofstra R M, Osinga J, Mecklin J P, Järvinen H J, Leisti J, Buys C H, de la Chapelle A, Peltomäki P

机构信息

Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.

出版信息

Hum Mol Genet. 1996 Jun;5(6):763-9. doi: 10.1093/hmg/5.6.763.

Abstract

The DNA mismatch repair genes MSH2 and MLH1 have been shown to account for a major share of hereditary non-polyposis colorectal cancer (HNPCC). We searched for germline mutations in these genes in 35 HNPCC kindreds fulfilling the Amsterdam diagnostic criteria and in a further 20 kindreds with an average of four affected members per family but not meeting the formal criteria. We first screened for truncations by reverse transcriptase (RT)-PCR. If no mutation was found, we screened genomic DNA by a novel application of two-dimensional (2-D) DNA electrophoresis that allows the simultaneous study of all exons of each gene. All abnormalities were followed up by sequencing. Eight different pathogenic germline mutations were found, two in MSH2 and six in MLH1. We report three major conclusions. First, these mutations together accounted for 86% (30/35) of the kindreds meeting the Amsterdam criteria, but only 30% (6/20) of the remaining kindreds, suggesting differences in etiology. Second, MLH1 was involved in > 90% (34/36) of kindreds with a known predisposing mutation, suggesting that mutations in the MLH1 gene are responsible for most HNPCC kindreds in Finland. Third, our results indicate that the successive application of RT-PCR and 2-D DNA electrophoresis is a sensitive and efficient method for mutation screening in typical HNPCC.

摘要

DNA错配修复基因MSH2和MLH1已被证明在遗传性非息肉病性结直肠癌(HNPCC)中占主要比例。我们在35个符合阿姆斯特丹诊断标准的HNPCC家族以及另外20个平均每个家族有4名患病成员但不符合正式标准的家族中,搜索了这些基因的种系突变。我们首先通过逆转录酶(RT)-PCR筛选截短突变。如果未发现突变,我们通过二维(2-D)DNA电泳的新应用筛选基因组DNA,该方法允许同时研究每个基因的所有外显子。所有异常情况均通过测序进行随访验证。我们发现了8种不同的致病性种系突变,其中2种在MSH2中,6种在MLH1中。我们报告了三个主要结论。第一,这些突变共同占符合阿姆斯特丹标准家族的86%(30/35),但仅占其余家族的30%(6/20),这表明病因存在差异。第二,在已知有易感突变的家族中>90%(34/36)涉及MLH1基因,这表明MLH1基因突变是芬兰大多数HNPCC家族的病因。第三,我们的结果表明,RT-PCR和二维DNA电泳的连续应用是典型HNPCC突变筛查的一种灵敏且有效的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验